Exhibit 99.1
INVESTOR CONTACT
Minaxi Patel
Synopsys, Inc.
650-584-1901
EDITORIAL CONTACT:
Yvette Huygen
Synopsys, Inc.
650-584-4547
Synopsys Posts Financial Results for
Third Quarter of Fiscal 2004
MOUNTAIN VIEW, Calif. August 18, 2004 – Synopsys, Inc. (Nasdaq: SNPS), the world leader in semiconductor design software, today reported results for its third quarter ended July 31, 2004.
For the third quarter of fiscal 2004, Synopsys reported revenue of $281.7 million, a 6% decrease compared to revenue of $300.4 million for the third quarter of fiscal 2003. For the nine-month period ended July 31, 2004, revenue was $861.5 million compared to revenue of $860.5 million for the same period in 2003.
GAAP Results
On a generally accepted accounting principles (GAAP) basis, for the third quarter of fiscal 2004, net income was $41.8 million, or $0.26 per share, compared to net income of $48.5 million, or $0.30 per share, for the third quarter of fiscal 2003. GAAP net income for the nine-month period ended July 31, 2004 was $102.7 million, or $0.63 per share, compared to $105.1 million, or $0.67 per share, for the same period in fiscal 2003.
1
Non-GAAP Results
On a non-GAAP basis, net income was $53.2 million, or $0.33 per share, for the third quarter of fiscal 2004 compared to non-GAAP net income of $66.9 million, or $0.41 per share, for the third quarter of fiscal 2003. Non-GAAP net income for the nine-month period ended July 31, 2004 was $164.6 million, or $1.01 per share, compared to $180.5 million, or $1.15 per share, for the same period in fiscal 2003.
A description of the items excluded from non-GAAP results and a reconciliation of GAAP and non-GAAP results are contained in the section entitled “GAAP Reconciliation” below. Per share data for the periods presented reflects Synopsys’ two-for-one stock split completed on September 23, 2003.
Third Quarter Business Environment
“Clearly, our third quarter was tough, mainly due to lower-than-expected bookings for upfront licenses, with several contracts being pushed out very late in the quarter,” said Aart de Geus, Chairman and Chief Executive Officer. “In July, customers became markedly more cautious about extending existing commitments and spending cash, particularly impacting our upfront bookings, which under our model require front-loaded payment terms. Recent announcements in the industry of lower earnings and reduced forecasts suggest continued caution on customer spending. This caution, and the fact that we anticipate 2005 will be a relatively low renewal year for Synopsys, will reduce our bookings expectations for fiscal 2005.”
“Against this backdrop, with new technology rolling out this year and accelerating in 2005, and with the advantage of a strong existing backlog, we have decided to move Synopsys immediately towards a maximally subscription-based license model,” continued Dr. de Geus. “We believe this further transition offers the best opportunity to preserve the value of our new technology, aggressively pursue competitive displacements, decrease end-of-quarter uncertainty, and more flexibly offer customers complete, differentiated solutions to match their current needs. Moving away from upfront licenses will in the near-term lower our fourth quarter, fiscal 2004 and fiscal 2005 revenue expectations, but we believe it is the right action to put Synopsys on the strongest long-term footing.”
2
2004 Financial Targets
Synopsys also announced its operating model targets for the fourth quarter of fiscal 2004 and revised targets for the full fiscal year. These targets reflect Synopsys’ expectations of a shift in the mix of license revenues during the fourth quarter.
Fourth Quarter of Fiscal 2004 Targets:
• Revenue: $220 million - $240 million
• Non-GAAP expenses: $222 million - $232 million
• Other income and expense: ($1.5) million – $1.5 million
• Fully diluted outstanding shares: 150 million - 158 million
• Tax rate applied in net income calculations: 31%
• Non-GAAP earnings: $0.00 - $0.04 per share
• Revenue from backlog: over 90% of revenue target
Revised Fiscal 2004 Targets:
• Revenue: $1.08 billion - $1.1 billion
• Non-GAAP expenses: $846 million - $856 million
• Fully diluted outstanding shares: 158 million - 162 million
• Non-GAAP earnings: $1.01 - $1.05 per share
Synopsys’ orders for the year are expected to be below its previous target of $1.4 billion. Synopsys is not providing a new total orders target for fiscal 2004 or an updated target for upfront orders as a percentage of product orders for the year. Both of these metrics will be materially affected, more so than in other quarters, by the timing of completion of certain agreements currently being negotiated. Synopsys intends to report on its orders results for the year when it reports its fourth quarter results.
3
Preliminary Fiscal 2005 Financial Targets
Synopsys’ preliminary operating model targets for fiscal 2005 are as follows:
• Orders: approximately $900 million
• Revenue: approximately $940 million
• Non-GAAP earnings: $0.28 - $0.38 per share
The fourth quarter, full-year fiscal 2004 and preliminary fiscal 2005 financial targets constitute forward-looking information based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see the section entitled “Forward-Looking Statements” below.
GAAP Reconciliation
Non-GAAP net income consists of GAAP net income excluding, to the extent incurred in a particular quarter, amortization of intangible assets and deferred stock compensation, in-process research and development charges, integration and other acquisition-related expenses and facilities and workforce realignment charges. Intangible assets consist primarily of purchased technology, contract rights intangible, customer-installed base/relationships, trademarks and tradenames, covenants not to compete and customer backlog. Non-GAAP net income is reduced by the amount of additional taxes that Synopsys would accrue if it used non-GAAP results instead of GAAP results to calculate Synopsys’ tax liability.
Synopsys’ management evaluates and makes operating decisions primarily based on the bookings and revenues of its core software and services business operations and the direct, ongoing and recurring costs of those operations such as cost of revenues and research and development, sales and marketing and general and administrative expenses. Management does not believe amortization of intangible assets and deferred stock compensation, in-process research and development charges, integration and other acquisition-related expenses and facilities and workforce realignment charges are ordinary, ongoing and recurring operating charges for Synopsys’ core software and services business operations. Therefore, management calculates the non-GAAP financial measures used in this earnings release excluding these charges and uses these non-GAAP financial measures to enable it
4
to analyze further and more consistently the period-to-period financial performance of its core business operations. Management believes that, although it is important for investors to understand GAAP measures, providing investors with these non-GAAP measures gives them additional important information to enable them to assess, in a way management assesses, Synopsys’ current and future continuing operations.
5
Reconciliation of Third Quarter Results
The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP results for the periods indicated below:
Income Statement Reconciliation
| | Three Months Ended July 31, | | Nine Months Ended July 31, | |
(in thousands) | | 2004 | | 2003 | | 2004 | | 2003 | |
| | | | | | | | | |
GAAP net income | | $ | 41,828 | | $ | 48,475 | | $ | 102,719 | | $ | 105,149 | |
Amortization of intangible assets and deferred stock compensation | | 34,092 | | 33,077 | | 102,927 | | 95,338 | |
Merger termination fee | | — | | — | | 10,000 | | — | |
In process research and development | | — | | 1,600 | | — | | 19,850 | |
Realignment charges, net of those settled at a lower cost than estimated | | — | | — | | 513 | | — | |
Collection of acquired accounts receivable originally assumed uncollectable | | — | | (3,000 | ) | — | | (3,000 | ) |
Pre-merger liabilities settled at a lower cost than estimated | | — | | (616 | ) | — | | (616 | ) |
Tax effect | | (22,692 | ) | (12,652 | ) | (51,525 | ) | (36,179 | ) |
Non-GAAP net income | | $ | 53,228 | | $ | 66,884 | | $ | 164,634 | | $ | 180,542 | |
Income Statement Reconciliation Per Share
| | Three Months Ended July 31, | | Nine Months Ended July 31, | |
(in thousands, except per share data) | | 2004 | | 2003 | | 2004 | | 2003 | |
| | | | | | | | | |
GAAP earnings per share | | $ | 0.26 | | $ | 0.30 | | $ | 0.63 | | 0.67 | |
Amortization of intangible assets and deferred stock compensation | | 0.21 | | 0.20 | | 0.63 | | 0.61 | |
Merger termination fee | | — | | — | | 0.06 | | — | |
In process research and development | | — | | 0.01 | | — | | 0.13 | |
Realignment charges, net of those settled at a lower cost than estimated | | — | | — | | — | | — | |
Collection of acquired accounts receivable originally assumed uncollectable | | — | | (0.02 | ) | — | | (0.02 | ) |
Pre-merger liabilities settled at a lower cost than estimated | | — | | — | | — | | — | |
Tax effect | | (0.14 | ) | (0.08 | ) | (0.31 | ) | (0.24 | ) |
Non-GAAP earnings per share | | $ | 0.33 | | $ | 0.41 | | $ | 1.01 | | $ | 1.15 | |
| | | | | | | | | |
Shares used in calculation | | 160,346 | | 162,696 | | 162,638 | | 156,320 | |
| | | | | | | | | | | | | |
6
Reconciliation of Estimated Target Operating Results
The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP results for the periods indicated below:
Non-GAAP Target Expenses Reconciliation
| | Range for Three Months Ending October 31, 2004 | |
(in thousands) | | Low | | High | |
GAAP target expenses | | $ | 256,000 | | $ | 268,000 | |
Impact of amortization of intangible assets and deferred stock compensation | | (34,000 | ) | (35,000 | ) |
Impact of known facility realignment charges | | — | | (1,000 | ) |
Non-GAAP target expenses | | $ | 222,000 | | $ | 232,000 | |
Non-GAAP Target Expenses Reconciliation
| | Range for Fiscal Year Ending October 31, 2004 | |
(in thousands) | | Low | | High | |
GAAP target expenses | | $ | 993,000 | | $ | 1,006,000 | |
Merger termination fee | | (10,000 | ) | (10,000 | ) |
Estimated impact of amortization of intangible assets and deferred stock compensation | | (137,000 | ) | (138,000 | ) |
Estimated impact of known facility realignment charges | | — | | (2,000 | ) |
Non-GAAP Target Expenses | | $ | 846,000 | | $ | 856,000 | |
Information regarding Target Earnings Per Share
| | Range for Three Months Ending October 31, 2004 | |
(in thousands, except per share data) | | Low | | High | |
| | | | | |
GAAP target earnings per share | | $ | (0.15 | ) | $ | (0.12 | ) |
Impact of amortization of intangible assets and deferred stock compensation per share, net of tax effect | | 0.15 | | 0.16 | |
Impact of facility realignment charges per share, net of tax effect | | — | | — | |
Non-GAAP target earnings per share | | $ | — | | $ | 0.04 | |
| | | | | |
Shares used in calculation (midpoint of target range) | | 154,000 | | 154,000 | |
7
Information regarding Target Earnings Per Share
| | Range for Fiscal Year Ending October 31, 2004 | |
(in thousands, except per share data) | | Low | | High | |
| | | | | |
GAAP target earnings per share | | $ | 0.41 | | $ | 0.43 | |
Impact of amortization of intangible assets and deferred stock compensation per share, net of tax effect | | 0.59 | | 0.60 | |
Impact of facility realignment charges per share, net of tax effect | | 0.01 | | 0.02 | |
Non-GAAP target earnings per share | | $ | 1.01 | | $ | 1.05 | |
| | | | | |
Shares used in calculation (midpoint of target range) | | 160,000 | | 160,000 | |
Information regarding Target Earnings Per Share
| | Range for Fiscal Year Ending October 31, 2005 | |
(in thousands, except per share data) | | Low | | High | |
| | | | | |
Preliminary GAAP target earnings per share | | $ | (0.16 | ) | $ | (0.07 | ) |
Impact of amortization of intangible assets and deferred stock compensation per share, net of tax effect | | 0.44 | | 0.45 | |
Preliminary non-GAAP target earnings per share | | $ | 0.28 | | $ | 0.38 | |
| | | | | |
Shares used in calculation | | 154,000 | | 154,000 | |
Additional Financial Information Available on Synopsys Website
In connection with the issuance of this earnings release, Synopsys is making available to investors supplemental financial information, which can be found on Synopsys’ website at http://www.synopsys.com/corporate/invest/finsupp/q304.pdf. Synopsys currently intends to provide this information on a quarterly basis.
Earnings Call Open to Investors
Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m., Pacific Time. A live webcast of the call will be available at Synopsys’ corporate website at http://www.synopsys.com/corporate/invest/invest.html. A recording of the call will be available by calling 1-800-288-8976 (612-332-0226 for international callers), access code 741248, beginning at 5:30 p.m. Pacific Time today. A webcast replay will also be available at http://www.synopsys.com/corporate/invest/invest.html from
8
approximately 5:30 p.m. Pacific Time today through the time of the announcement of Synopsys’ results for the fourth quarter of fiscal 2004 in December 2004. Finally, Synopsys will post copies of the prepared remarks of Aart de Geus, Chairman and Chief Executive Officer, and Steve Shevick, Chief Financial Officer, on its website at http://www.synopsys.com/corporate/invest/invest.html following the call.
Effectiveness of Information
The targets included in this release, the statements made during the earnings conference call and the information contained in the financial supplement represent Synopsys’ expectations and beliefs as of the date of this release only. Although this release, copies of the prepared remarks of the CEO and CFO made during the call and the financial supplement will remain available on Synopsys’ website through the date of the fourth quarter earnings call in December 2004, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys does not currently intend to report on its progress during the fourth quarter of fiscal 2004 or comment to analysts or investors on, or otherwise update, the targets given in this earnings release until it releases such results in December 2004. Furthermore, Synopsys is under no obligation to (and expressly disclaims any such obligation to) update or alter any of the forward-looking statements made in this earnings release, the conference call or the financial supplement whether as a result of new information, future events or otherwise unless required by law.
Availability of Final Financial Statements
Synopsys will include final financial statements for the third quarter of fiscal 2004 in its Quarterly Report on Form 10-Q to be filed in September 2004.
About Synopsys
Synopsys, Inc. (Nasdaq: SNPS) is the world leader in electronic design automation (EDA) software for semiconductor design. The company delivers technology-leading semiconductor design and verification platforms and IC manufacturing software products to the global electronics market, enabling the development and production of complex systems-on-chips (SoCs). Synopsys also provides intellectual property and design services
9
to simplify the design process and accelerate time-to-market for its customers. Synopsys is headquartered in Mountain View, California and has offices in more than 60 locations throughout North America, Europe, Japan and Asia. Visit Synopsys online at http://www.synopsys.com/.
Forward-Looking Statements
The statements made in this press release regarding projected or expected future events or financial results in the sections entitled “Third Quarter Business Environment”, “Fiscal 2004 Financial Targets”, “Preliminary Fiscal 2005 Financial Targets” and “GAAP Reconciliation” are forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially from those described by these statements due to a number of uncertainties, including but not limited to the risk of:
• continued weakness or continued budgetary caution in the semiconductor or electronic systems industries;
• lower-than-expected research and development spending by semiconductor and electronic systems companies;
• lower-than-anticipated purchases or delays in purchases of software or consulting services by Synopsys’ customers, including delays in the renewal, or non-renewal, of Synopsys’ license arrangements with major customers;
• unexpected changes in the mix of time-based licenses and upfront licenses;
• lower-than-expected bookings of licenses on which revenue is recognized upfront;
• lower-than-anticipated new IC design starts;
• competition in the market for Synopsys’ products and services;
• failure to continue to improve Synopsys’ existing products;
• failure to successfully develop additional intellectual property blocks for its IP business or to develop and integrate its design for manufacturing products;
• difficulties in the ongoing integration of the products and operations of acquired companies or assets into Synopsys’ products and operations;
10
• adverse variations from currently projected customer payment terms; and
• downward pressure on maintenance orders, adversely affecting Synopsys’ future level of service revenue.
In addition, Synopsys’ actual expenses and earnings per share on a GAAP basis for the fourth quarter of fiscal 2004 and actual earnings per share on a GAAP basis for the full fiscal years 2004 and 2005 could differ materially from the targets stated under “Fiscal 2004 Financial Targets” and “Preliminary Fiscal 2005 Financial Targets” above for a number of reasons, including (i) a determination by Synopsys that any portion of its intangible assets have become impaired, (ii) changes in deferred stock compensation expenses caused by employee terminations, and (iii) integration and other acquisition-related expenses, amortization of additional intangible assets and deferred stock compensation associated with future acquisitions, if any.
For further discussion of these and other factors that may cause results to differ from those projected in this release, readers are referred to the reports Synopsys has filed with the Securities and Exchange Commission, and available at www.sec.gov, specifically the section contained in Part I, Item 2 of Synopsys’ Quarterly Report on Form 10-Q for the second quarter of fiscal 2004 filed with the Commission on June 10, 2004 entitled “Factors That May Affect Future Results.”
#######
Synopsys is a registered trademark of Synopsys, Inc. All other trademarks mentioned in this release are the intellectual property of their respective owners.
11
SYNOPSYS, INC.
Unaudited Condensed Consolidated Statements of Income (1)
(in thousands, except per share data)
| | Three Months Ended July 31, 2004 (2) | | Three Months Ended July 31, 2003 (2) | |
| | GAAP Basis | | Adjustments | | Non-GAAP Basis | | GAAP Basis | | Adjustments | | Non-GAAP Basis | |
Revenue: | | | | | | | | | | | | | |
Upfront license | | $ | 62,352 | | — | | $ | 62,352 | | $ | 74,709 | | — | | $ | 74,709 | |
Time-based license | | 164,398 | | — | | 164,398 | | 160,875 | | — | | 160,875 | |
Service | | 54,931 | | — | | 54,931 | | 64,782 | | — | | 64,782 | |
Total revenue | | 281,681 | | — | | 281,681 | | 300,366 | | — | | 300,366 | |
Cost of revenue: | | | | | | | | | | | | | |
Upfront license | | 3,277 | | — | | 3,277 | | 3,536 | | — | | 3,536 | |
Time-based license | | 15,550 | | — | | 15,550 | | 13,792 | | — | | 13,792 | |
Service | | 19,929 | | — | | 19,929 | | 16,974 | | — | | 16,974 | |
Amortization of intangible assets and deferred stock compensation | | 25,562 | | (25,562 | ) | — | | 23,856 | | (23,856 | ) | — | |
Total cost of revenue | | 64,318 | | (25,562 | ) | 38,756 | | 58,158 | | (23,856 | ) | 34,302 | |
Gross margin | | 217,363 | | 25,562 | | 242,925 | | 242,208 | | 23,856 | | 266,064 | |
Operating expenses: | | | | | | | | | | | | | |
Research and development | | 68,471 | | — | | 68,471 | | 70,716 | | — | | 70,716 | |
Sales and marketing | | 70,395 | | — | | 70,395 | | 78,189 | | — | | 78,189 | |
General and administrative | | 28,194 | | — | | 28,194 | | 19,763 | | 3,000 | | 22,763 | |
In-process research and development | | — | | — | | — | | 1,600 | | (1,600 | ) | — | |
Amortization of intangible assets and deferred stock compensation | | 8,530 | | (8,530 | ) | — | | 9,221 | | (9,221 | ) | — | |
Total operating expenses | | 175,590 | | (8,530 | ) | 167,060 | | 179,489 | | (7,821 | ) | 171,668 | |
Operating income | | 41,773 | | 34,092 | | 75,865 | | 62,719 | | 31,677 | | 94,396 | |
Other income, net | | 1,277 | | — | | 1,277 | | 5,307 | | (616 | ) | 4,691 | |
Income before provision for income taxes | | 43,050 | | 34,092 | | 77,142 | | 68,026 | | 31,061 | | 99,087 | |
Provision for income taxes | | 1,222 | | 22,692 | | 23,914 | | 19,551 | | 12,652 | | 32,203 | |
Net income | | $ | 41,828 | | $ | 11,400 | | $ | 53,228 | | $ | 48,475 | | $ | 18,409 | | $ | 66,884 | |
Basic earnings per share: | | | | | | | | | | | | | |
Net income per share | | $ | 0.27 | | | | $ | 0.34 | | $ | 0.32 | | | | $ | 0.44 | |
Weighted-average common shares | | 155,199 | | | | 155,199 | | 153,240 | | | | 153,240 | |
Diluted earnings per share: | | | | | | | | | | | | | |
Net income per share | | $ | 0.26 | | | | $ | 0.33 | | $ | 0.30 | | | | $ | 0.41 | |
Weighted-average common shares and equivalents | | 160,346 | | | | 160,346 | | 162,696 | | | | 162,696 | |
| | | | | | | | | | | | | | | | | | | |
(1) Synopsys’ fiscal year and third quarter ends on the Saturday nearest to October 31 and July 31, respectively. For presentation purposes, the unaudited condensed consolidated financial statements refer to a calendar month end.
(2) All common share and per share data for all periods presented are adjusted to reflect Synopsys’ two-for-one stock split completed on September 23, 2003.
12
| | Nine Months Ended July 31, 2004 (2) | | Nine Months Ended July 31, 2003 (2) | |
| | GAAP Basis | | Adjustments | | Non-GAAP Basis | | GAAP Basis | | Adjustments | | Non-GAAP Basis | |
Revenue: | | | | | | | | | | | | | |
Upfront license | | $ | 197,654 | | — | | $ | 197,654 | | $ | 211,229 | | — | | $ | 211,229 | |
Time-based license | | 497,942 | | — | | 497,942 | | 450,165 | | — | | 450,165 | |
Service | | 165,953 | | — | | 165,953 | | 199,136 | | — | | 199,136 | |
Total revenue | | 861,549 | | — | | 861,549 | | 860,530 | | — | | 860,530 | |
Cost of revenue: | | | | | | | | | | | | | |
Upfront license | | 17,473 | | 197 | | 17,670 | | 11,134 | | — | | 11,134 | |
Time-based license | | 31,305 | | — | | 31,305 | | 40,050 | | — | | 40,050 | |
Service | | 65,043 | | 111 | | 65,154 | | 56,744 | | — | | 56,744 | |
Amortization of intangible assets and deferred stock compensation | | 76,517 | | (76,517 | ) | — | | 68,959 | | (68,959 | ) | — | |
Total cost of revenue | | 190,338 | | (76,209 | ) | 114,129 | | 176,887 | | (68,959 | ) | 107,928 | |
Gross margin | | 671,211 | | 76,209 | | 747,420 | | 683,643 | | 68,959 | | 752,602 | |
Operating expenses: | | | | | | | | | | | | | |
Research and development | | 208,944 | | 754 | | 209,698 | | 206,597 | | — | | 206,597 | |
Sales and marketing | | 216,026 | | 580 | | 216,606 | | 230,397 | | — | | 230,397 | |
General and administrative | | 95,805 | | (12,155 | ) | 83,650 | | 66,554 | | 3,000 | | 69,554 | |
In-process research and development | | — | | — | | — | | 19,850 | | (19,850 | ) | — | |
Amortization of intangible assets and deferred stock compensation | | 26,410 | | (26,410 | ) | — | | 26,379 | | (26,379 | ) | — | |
Total operating expenses | | 547,185 | | (37,231 | ) | 509,954 | | 549,777 | | (43,229 | ) | 506,548 | |
Operating income | | 124,026 | | 113,440 | | 237,466 | | 133,866 | | 112,188 | | 246,054 | |
Other (expense) income, net | | 1,133 | | — | | 1,133 | | 22,032 | | (616 | ) | 21,416 | |
Income before provision for income taxes | | 125,159 | | 113,440 | | 238,599 | | 155,898 | | 111,572 | | 267,470 | |
Provision for income taxes | | 22,440 | | 51,525 | | 73,965 | | 50,749 | | 36,179 | | 86,928 | |
Net income | | $ | 102,719 | | $ | 61,915 | | $ | 164,634 | | $ | 105,149 | | $ | 75,393 | | $ | 180,542 | |
Basic earnings per share: | | | | | | | | | | | | | |
Net income per share | | $ | 0.66 | | | | $ | 1.06 | | $ | 0.70 | | | | $ | 1.20 | |
Weighted-average common shares | | 155,437 | | | | 155,437 | | 150,008 | | | | 150,008 | |
Diluted earnings per share: | | | | | | | | | | | | | |
Net income per share | | $ | 0.63 | | | | $ | 1.01 | | $ | 0.67 | | | | $ | 1.15 | |
Weighted-average common shares and equivalents | | 162,638 | | | | 162,638 | | 156,320 | | | | 156,320 | |
| | | | | | | | | | | | | | | | | | | |
(1) Synopsys’ fiscal year and third quarter ends on the Saturday nearest to October 31 and July 31, respectively. For presentation purposes, the unaudited condensed consolidated financial statements refer to a calendar month end.
(2) All common share and per share data for all periods presented are adjusted to reflect Synopsys’ two-for-one stock split completed on September 23, 2003.
13
SYNOPSYS, INC.
Unaudited Condensed Consolidated Balance Sheets (1)
(in thousands)
| | July 31, 2004 | | October 31, 2003 | |
ASSETS: | | | | | |
Current assets: | | | | | |
Cash and cash equivalents | | $ | 499,234 | | $ | 524,308 | |
Short-term investments | | 200,111 | | 174,049 | |
Total cash, cash equivalents and short-term investments | | 699,345 | | 698,357 | |
Accounts receivable, net of allowances of $7,848 and $8,295, respectively | | 143,006 | | 200,998 | |
Deferred income taxes | | 243,106 | | 248,425 | |
Income taxes receivable | | 49,223 | | 72,124 | |
Prepaid expenses and other current assets | | 30,081 | | 19,302 | |
Total current assets | | 1,164,761 | | 1,239,206 | |
Property and equipment, net | | 180,081 | | 184,313 | |
Long-term investments | | 13,458 | | 8,595 | |
Goodwill | | 570,047 | | 550,732 | |
Intangible assets, net | | 213,155 | | 285,583 | |
Other assets | | 80,054 | | 38,924 | |
Total assets | | $ | 2,221,556 | | $ | 2,307,353 | |
| | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY: | | | | | |
Current liabilities: | | | | | |
Accounts payable and accrued liabilities | | $ | 159,407 | | $ | 204,226 | |
Accrued income taxes | | 182,569 | | 201,855 | |
Deferred revenue | | 385,302 | | 398,878 | |
Total current liabilities | | 727,278 | | 804,959 | |
Deferred compensation and other liabilities | | 51,521 | | 47,390 | |
Long-term deferred revenue | | 29,215 | | 21,594 | |
Stockholders’ equity (2): | | | | | |
Common stock, $0.01 par value; 400,000 shares authorized; 154,779 and 155,837 shares outstanding, respectively | | 1,548 | | 1,560 | |
Additional paid-in capital | | 1,240,384 | | 1,198,421 | |
Retained earnings | | 249,844 | | 251,979 | |
Treasury stock, at cost; 2,350 and 662 shares, respectively | | (74,834 | ) | (20,733 | ) |
Deferred stock compensation | | (3,543 | ) | (7,170 | ) |
Accumulated other comprehensive income | | 143 | | 9,353 | |
Total stockholders’ equity | | 1,413,542 | | 1,433,410 | |
Total liabilities and stockholders’ equity | | $ | 2,221,556 | | $ | 2,307,353 | |
(1) Synopsys’ fiscal year and third quarter ends on the Saturday nearest to October 31 and July 31, respectively. For presentation purposes, the unaudited condensed consolidated financial statements refer to a calendar month end.
(2) All common share and per share data for all periods presented are adjusted to reflect Synopsys’ two-for-one stock split completed on September 23, 2003.
14
SYNOPSYS, INC.
Unaudited Condensed Consolidated Statements of Cash Flows (1)
(in thousands)
| | Three Months Ended July 31, | | Nine Months Ended July 31, | |
| | 2004 | | 2003 | | 2004 | | 2003 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | |
Net income | | $ | 41,828 | | $ | 48,475 | | $ | 102,719 | | $ | 105,149 | |
| | | | | | | | | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | | |
Amortization and depreciation | | 48,258 | | 46,898 | | 144,530 | | 137,773 | |
Deferred taxes | | — | | — | | — | | — | |
In-process research and development | | — | | 1,600 | | — | | 19,850 | |
Write-down of long-term investments | | — | | 1,877 | | 1,901 | | 3,942 | |
Tax benefit associated with stock options | | — | | — | | — | | 3,226 | |
Deferred rent | | 71 | | 209 | | — | | 1,560 | |
Provision for doubtful accounts and sales returns | | (2,000 | ) | (4,000 | ) | — | | (1,577 | ) |
Net change in unrecognized gains and losses on foreign exchange contracts | | (3,458 | ) | (3,637 | ) | (11,142 | ) | 15,640 | |
Gain on sale of short- and long-term investments | | (111 | ) | (8,098 | ) | (867 | ) | (20,568 | ) |
Net changes in operating assets and liabilities: | | | | | | | | | |
Accounts receivable | | 79,865 | | 47,944 | | 58,134 | | 6,379 | |
Income taxes receivable | | (1 | ) | — | | 22,795 | | 2,038 | |
Prepaid expenses and other current assets | | 3,255 | | (8,485 | ) | (10,779 | ) | (7,391 | ) |
Other assets | | (2,230 | ) | 20,870 | | (13,449 | ) | 18,535 | |
Accounts payable and accrued liabilities | | 1,252 | | 10,545 | | (49,042 | ) | (54,888 | ) |
Accrued income taxes | | 900 | | (2,921 | ) | (19,286 | ) | 2,156 | |
Deferred revenue | | (37,366 | ) | (29,393 | ) | (6,097 | ) | 33,500 | |
Deferred compensation | | 211 | | 3,369 | | 11,053 | | 7,992 | |
Net cash provided by operating activities | | 130,474 | | 125,253 | | 230,470 | | 273,316 | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | |
Proceeds from sales and maturities of short-term investments | | 262,330 | | 66,030 | | 795,643 | | 179,829 | |
Purchases of short-term investments | | (305,556 | ) | (84,853 | ) | (821,655 | ) | (219,099 | ) |
Proceeds from sale of long-term investments | | 112 | | 13,775 | | 412 | | 32,006 | |
Purchases of long-term investments | | (4,890 | ) | — | | (6,144 | ) | (800 | ) |
Purchases of property and equipment, net | | (10,944 | ) | (13,838 | ) | (35,073 | ) | (33,543 | ) |
Cash paid for acquisitions, net of cash received | | (915 | ) | (5,283 | ) | (39,730 | ) | (167,744 | ) |
Capitalization of software development costs | | (685 | ) | (654 | ) | (2,056 | ) | (1,962 | ) |
Net cash used in investing activities | | (60,548 | ) | (24,823 | ) | (108,603 | ) | (211,313 | ) |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | |
Proceeds from credit facility | | — | | — | | 200,000 | | — | |
Payments on credit facility | | — | | — | | (200,000 | ) | — | |
Issuances of common stock | | 23,896 | | 216,269 | | 141,892 | | 279,688 | |
Purchases of treasury stock | | (49,998 | ) | (158,855 | ) | (288,336 | ) | (226,650 | ) |
| | | | | | | | | |
Net cash (used in) provided by financing activities | | (26,102 | ) | 57,414 | | (146,444 | ) | 53,038 | |
Effect of exchange rate changes on cash | | (713 | ) | (382 | ) | (497 | ) | (1,337 | ) |
Net decrease in cash and cash equivalents | | 43,111 | | 157,462 | | (25,074 | ) | 113,704 | |
Cash and cash equivalents, beginning of period | | 456,123 | | 268,822 | | 524,308 | | 312,580 | |
Cash and cash equivalents, end of period | | $ | 499,234 | | $ | 426,284 | | $ | 499,234 | | $ | 426,284 | |
(1) Synopsys’ fiscal year and third quarter ends on the Saturday nearest to October 31 and July 31, respectively. For presentation purposes, the unaudited condensed consolidated financial statements refer to a calendar month end.
15